Tuesday 3 November 2026 Export UNH’s income statement to Excel — free account

UnitedHealth Group Incorporated

UnitedHealth Group Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $447.6 billion, up 11.8% from fiscal 2024.

Revenue: −0.41%
EPS: +76.1%
Free cash flow: −15.7%
Total debt: −5.09%

Quarter to September 2026, against a year earlier

400.24 6.73 −1.65%

Follow UNH

Alert me

Market cap: $359.4B
P/E: 22.9×
Fwd P/E: 21.1×
Dividend yield: 2.26%
F-score: 6/9
Altman Z: 2.84
Beneish M: −2.41
Dividend safety: 76/100

Overview Business Profile Earnings & Analysis Segments Filings

UnitedHealth Group Incorporated (UNH) revenue by segment, product and region

Revenue by segment $m

Line	FY2011	FY2010	FY2009
UnitedHealthcare	95,336 93.59%	88,730 94.24%	82,730 94.94%
Optum Rx	19,278 18.93%	16,724 17.76%	14,401 16.53%
Optum Health	6,704 6.58%	4,565 4.85%	4,212 4.83%
Optum Insight	2,671 2.62%	2,342 2.49%	1,823 2.09%
Intersegment Eliminations	(22,127) (21.72%)	(18,206) (19.34%)	(16,028) (18.39%)
Optum	28,653	23,631	20,436
Revenue	101,862	94,155	87,138

Operating income by segment $m, and margin

	FY2011	FY2010	FY2009
UnitedHealthcare	‡	‡	‡
Optum Rx	‡	‡	‡
Optum Health	‡	‡	‡
Optum Insight	‡	‡	‡
Intersegment Eliminations	‡	‡	‡
Corporate and other	‡	‡	‡
Operating income	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡
	‡	‡	‡

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Commercial - Domestic: Fee-based	Q3 FY2026	22.2M	21.5M	+3.21%
Commercial - Domestic: Risk-based	Q3 FY2026	7.6M	8.4M	−10.25%
Days claims payable	Q3 FY2026	47.00	46.20	+1.73%
Days sales outstanding	Q3 FY2026	16.90	18.60	−9.14%
Medicaid	Q3 FY2026	6.7M	7.5M	−10.25%
Medical care ratio	Q3 FY2026	88.4%	89.9%	—
Medicare Advantage	Q3 FY2026	7.6M	8.4M	−9.84%
Medicare Part D stand-alone	Q3 FY2026	2.7M	2.8M	−3.76%
Medicare Supplement (Standardized)	Q3 FY2026	4.2M	4.3M	−1.28%
Optum Health Consumers Served	Q3 FY2026	92.0M	96.0M	−4.17%
Optum Insight Contract Backlog	Q4 FY2025	$31.1B	$32.8B	−5.18%
Optum Rx Quarterly Adjusted Scripts	Q3 FY2026	393.0M	414.0M	−5.07%
Remaining performance obligations	Q2 FY2026	$10.7B	$11.9B	−10.08%
South American businesses held for sale	Q3 FY2026	1.1M	1.2M	−1.72%
Total Commercial - Domestic	Q3 FY2026	29.8M	29.9M	−0.58%
Total Community and Senior	Q3 FY2026	18.5M	20.2M	−8.17%
Total UnitedHealthcare - Medical	Q3 FY2026	48.3M	—	—

	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024	Q3 FY2024	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023	Q2 FY2023	Q1 FY2023	Q4 FY2022
Commercial - Domestic: Fee-based	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Commercial - Domestic: Risk-based	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Days claims payable	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Days sales outstanding	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Medicaid	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Medical care ratio	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Medicare Advantage	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Medicare Part D stand-alone	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Medicare Supplement (Standardized)	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Optum Health Consumers Served	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Optum Insight Contract Backlog	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Optum Rx Quarterly Adjusted Scripts	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Remaining performance obligations	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
South American businesses held for sale	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Total Commercial - Domestic	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Total Community and Senior	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Total UnitedHealthcare - Medical	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.